Importance: School and daycare closures were enforced as measures to confine the novel coronavirus disease 2019 (COVID-19) pandemic, based on the assumption that young children may play a key role in severe acute respiratory coronavirus 2 (SARS-CoV-2) spread. Given the grave consequences of contact restrictions for children, a better understanding of their contribution to the COVID-19 pandemic is of great importance. Objective: To describe the rate of SARS-CoV-2 infections and the seroprevalence of SARS-CoV-2 antibodies in children aged 1 to 10 years, compared with a corresponding parent of each child, in a population-based sample. Design, Setting, and Participants: This large-scale, multicenter, cross-sectional investigation (the COVID-19 BaWü study) enrolled children aged 1 to 10 years and a corresponding parent between April 22 and May 15, 2020, in southwest Germany. Exposures: Potential exposure to SARS-CoV-2. Main Outcomes and Measures: The main outcomes were infection and seroprevalence of SARS-CoV-2. Participants were tested for SARS-CoV-2 RNA from nasopharyngeal swabs by reverse transcription-polymerase chain reaction and SARS-CoV-2 specific IgG antibodies in serum by enzyme-linked immunosorbent assays and immunofluorescence tests. Discordant results were clarified by electrochemiluminescence immunoassays, a second enzyme-linked immunosorbent assay, or an in-house Luminex-based assay. Results: This study included 4964 participants: 2482 children (median age, 6 [range, 1-10] years; 1265 boys [51.0%]) and 2482 parents (median age, 40 [range, 23-66] years; 615 men [24.8%]). Two participants (0.04%) tested positive for SARS-CoV-2 RNA. The estimated SARS-CoV-2 seroprevalence was low in parents (1.8% [95% CI, 1.2-2.4%]) and 3-fold lower in children (0.6% [95% CI, 0.3-1.0%]). Among 56 families with at least 1 child or parent with seropositivity, the combination of a parent with seropositivity and a corresponding child with seronegativity was 4.3 (95% CI, 1.19-15.52) times higher than the combination of a parent who was seronegative and a corresponding child with seropositivity. We observed virus-neutralizing activity for 66 of 70 IgG-positive serum samples (94.3%). Conclusions and Relevance: In this cross-sectional study, the spread of SARS-CoV-2 infection during a period of lockdown in southwest Germany was particularly low in children aged 1 to 10 years. Accordingly, it is unlikely that children have boosted the pandemic. This SARS-CoV-2 prevalence study, which appears to be the largest focusing on children, is instructive for how ad hoc mass testing provides the basis for rational political decision-making in a pandemic.
Importance: School and daycare closures were enforced as measures to confine the novel coronavirus disease 2019 (COVID-19) pandemic, based on the assumption that young children may play a key role in severe acute respiratory coronavirus 2 (SARS-CoV-2) spread. Given the grave consequences of contact restrictions for children, a better understanding of their contribution to the COVID-19 pandemic is of great importance. Objective: To describe the rate of SARS-CoV-2 infections and the seroprevalence of SARS-CoV-2 antibodies in children aged 1 to 10 years, compared with a corresponding parent of each child, in a population-based sample. Design, Setting, and Participants: This large-scale, multicenter, cross-sectional investigation (the COVID-19 BaWü study) enrolled children aged 1 to 10 years and a corresponding parent between April 22 and May 15, 2020, in southwest Germany. Exposures: Potential exposure to SARS-CoV-2. Main Outcomes and Measures: The main outcomes were infection and seroprevalence of SARS-CoV-2. Participants were tested for SARS-CoV-2 RNA from nasopharyngeal swabs by reverse transcription-polymerase chain reaction and SARS-CoV-2 specific IgG antibodies in serum by enzyme-linked immunosorbent assays and immunofluorescence tests. Discordant results were clarified by electrochemiluminescence immunoassays, a second enzyme-linked immunosorbent assay, or an in-house Luminex-based assay. Results: This study included 4964 participants: 2482 children (median age, 6 [range, 1-10] years; 1265 boys [51.0%]) and 2482 parents (median age, 40 [range, 23-66] years; 615 men [24.8%]). Two participants (0.04%) tested positive for SARS-CoV-2 RNA. The estimated SARS-CoV-2 seroprevalence was low in parents (1.8% [95% CI, 1.2-2.4%]) and 3-fold lower in children (0.6% [95% CI, 0.3-1.0%]). Among 56 families with at least 1 child or parent with seropositivity, the combination of a parent with seropositivity and a corresponding child with seronegativity was 4.3 (95% CI, 1.19-15.52) times higher than the combination of a parent who was seronegative and a corresponding child with seropositivity. We observed virus-neutralizing activity for 66 of 70 IgG-positive serum samples (94.3%). Conclusions and Relevance: In this cross-sectional study, the spread of SARS-CoV-2 infection during a period of lockdown in southwest Germany was particularly low in children aged 1 to 10 years. Accordingly, it is unlikely that children have boosted the pandemic. This SARS-CoV-2 prevalence study, which appears to be the largest focusing on children, is instructive for how ad hoc mass testing provides the basis for rational political decision-making in a pandemic.
Authors: Roy M Anderson; Christophe Fraser; Azra C Ghani; Christl A Donnelly; Steven Riley; Neil M Ferguson; Gabriel M Leung; T H Lam; Anthony J Hedley Journal: Philos Trans R Soc Lond B Biol Sci Date: 2004-07-29 Impact factor: 6.237
Authors: Jakob Peter Armann; Natalie Diffloth; Arne Simon; Maren Doenhardt; Markus Hufnagel; Andreas Trotter; Dominik Schneider; Johannes Hübner; Reinhard Berner Journal: Dtsch Arztebl Int Date: 2020-05-22 Impact factor: 5.594
Authors: Andrea M Lerner; Robert W Eisinger; Douglas R Lowy; Lyle R Petersen; Rosemary Humes; Matthew Hepburn; M Cristina Cassetti Journal: Immunity Date: 2020-06-23 Impact factor: 31.745
Authors: Stephen M Kissler; Christine Tedijanto; Yonatan H Grad; Marc Lipsitch; Edward Goldstein Journal: Science Date: 2020-04-14 Impact factor: 47.728
Authors: Daniel F Gudbjartsson; Agnar Helgason; Hakon Jonsson; Olafur T Magnusson; Pall Melsted; Gudmundur L Norddahl; Jona Saemundsdottir; Asgeir Sigurdsson; Patrick Sulem; Arna B Agustsdottir; Berglind Eiriksdottir; Run Fridriksdottir; Elisabet E Gardarsdottir; Gudmundur Georgsson; Olafia S Gretarsdottir; Kjartan R Gudmundsson; Thora R Gunnarsdottir; Arnaldur Gylfason; Hilma Holm; Brynjar O Jensson; Aslaug Jonasdottir; Frosti Jonsson; Kamilla S Josefsdottir; Thordur Kristjansson; Droplaug N Magnusdottir; Louise le Roux; Gudrun Sigmundsdottir; Gardar Sveinbjornsson; Kristin E Sveinsdottir; Maney Sveinsdottir; Emil A Thorarensen; Bjarni Thorbjornsson; Arthur Löve; Gisli Masson; Ingileif Jonsdottir; Alma D Möller; Thorolfur Gudnason; Karl G Kristinsson; Unnur Thorsteinsdottir; Kari Stefansson Journal: N Engl J Med Date: 2020-04-14 Impact factor: 91.245
Authors: Louise Benning; Christian Morath; Marie Bartenschlager; Christian Nusshag; Florian Kälble; Mirabel Buylaert; Matthias Schaier; Jörg Beimler; Katrin Klein; Julia Grenz; Paula Reichel; Asa Hidmark; Gerald Ponath; Maximilian Töllner; Marvin Reineke; Susanne Rieger; Burkhard Tönshoff; Paul Schnitzler; Martin Zeier; Caner Süsal; Ralf Bartenschlager; Claudius Speer Journal: Clin J Am Soc Nephrol Date: 2021-12-22 Impact factor: 8.237
Authors: Sebastian F N Bode; Marisa Haendly; Dorit Fabricius; Benjamin Mayer; Maria Zernickel; Anneke Donne Maree Haddad; Pauline Frieh; Roland Elling; Hanna Renk; Maximilian Stich; Eva-Maria Jacobsen; Klaus-Michael Debatin; Ales Janda Journal: Front Pediatr Date: 2022-06-30 Impact factor: 3.569
Authors: Anna Kern; Pia H Kuhlmann; Stefan Matl; Markus Ege; Nicole Maison; Jana Eckert; Ulrich von Both; Uta Behrends; Melanie Anger; Michael C Frühwald; Michael Gerstlauer; Joachim Woelfle; Antje Neubert; Michael Melter; Johannes Liese; David Goettler; Andreas Sing; Bernhard Liebl; Johannes Hübner; Christoph Klein Journal: Front Pediatr Date: 2022-07-06 Impact factor: 3.569
Authors: Constantin Pape; Roman Remme; Adrian Wolny; Sylvia Olberg; Steffen Wolf; Lorenzo Cerrone; Mirko Cortese; Severina Klaus; Bojana Lucic; Stephanie Ullrich; Maria Anders-Össwein; Stefanie Wolf; Berati Cerikan; Christopher J Neufeldt; Markus Ganter; Paul Schnitzler; Uta Merle; Marina Lusic; Steeve Boulant; Megan Stanifer; Ralf Bartenschlager; Fred A Hamprecht; Anna Kreshuk; Christian Tischer; Hans-Georg Kräusslich; Barbara Müller; Vibor Laketa Journal: Bioessays Date: 2020-12-30 Impact factor: 4.653
Authors: Lionel Larribère; Jelizaveta Gordejeva; Lisa Kuhnhenn; Maximilian Kurscheidt; Monika Pobiruchin; Dilyana Vladimirova; Maria Martin; Markus Roser; Wendelin Schramm; Uwe M Martens; Tatjana Eigenbrod Journal: Int J Environ Res Public Health Date: 2021-07-01 Impact factor: 3.390
Authors: Jared Bullard; Duane Funk; Kerry Dust; Lauren Garnett; Kaylie Tran; Alex Bello; James E Strong; Santina J Lee; Jillian Waruk; Adam Hedley; David Alexander; Paul Van Caeseele; Carla Loeppky; Guillaume Poliquin Journal: CMAJ Date: 2021-06-07 Impact factor: 8.262
Authors: Jakob Peter Armann; Carolin Kirsten; Lukas Galow; Elisabeth Kahre; Luise Haag; Alexander Dalpke; Christian Lück; Reinhard Berner Journal: BMJ Paediatr Open Date: 2021-03-24